Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H12O2 |
Molecular Weight | 164.2011 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(\C=C/C)=CC=C1O
InChI
InChIKey=BJIOGJUNALELMI-ARJAWSKDSA-N
InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3-7,11H,1-2H3/b4-3-
DescriptionSources: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2011/05/WC500106362.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/15606655Curator's Comment: description was created based on several sources, including
https://link.springer.com/article/10.1007/s00044-015-1486-6 | https://ntp.niehs.nih.gov/ntp/htdocs/chem_background/exsumpdf/isoeugenol_508.pdf | https://www.ncbi.nlm.nih.gov/pubmed/21995306
Sources: http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2011/05/WC500106362.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/15606655
Curator's Comment: description was created based on several sources, including
https://link.springer.com/article/10.1007/s00044-015-1486-6 | https://ntp.niehs.nih.gov/ntp/htdocs/chem_background/exsumpdf/isoeugenol_508.pdf | https://www.ncbi.nlm.nih.gov/pubmed/21995306
(E)-Isoeugenol is crystalline while compound with spice clove type odor. The melting point of E-isoeugenol is 33°C. E-Isoeugenol has been shown to cause contact and allergic dermatitis in humans. Positive skin patch tests in numerous individuals have confirmed the sensitizing ability of isoeugenol.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3816 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21995306 |
|||
Target ID: CHEMBL2169736 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27220325 |
|||
Target ID: CHEMBL2231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22686307 |
|||
Target ID: 57491.0 Gene Symbol: AHRR Sources: https://www.ncbi.nlm.nih.gov/pubmed/22686307 |
|||
Target ID: CHEMBL6007 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18456404 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | TRUE Test Approved UseUnknown |
|||
Diagnostic | TRUE Test Approved UseFragrance mix is composed of eight substances, including isoeugenol (approximately 15 ug). |
PubMed
Title | Date | PubMed |
---|---|---|
Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis. | 2000 Jun 8 |
|
Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. | 2001 Mar |
|
An odorant derivative as an antagonist for an olfactory receptor. | 2004 Nov |
|
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006 Nov |
|
Do anesthetics and sampling strategies affect transcription analysis of fish tissues? | 2007 Jun 8 |
|
Keratinocyte gene expression profiles discriminate sensitizing and irritating compounds. | 2010 Sep |
|
Active transport of contact allergens in human monocyte-derived dendritic cells is mediated by multidrug resistance related proteins. | 2011 Apr 15 |
|
The mouse eugenol odorant receptor: structural and functional plasticity of a broadly tuned odorant binding pocket. | 2011 Feb 8 |
|
B cell increases and ex vivo IL-2 production as secondary endpoints for the detection of sensitizers in non-radioisotopic local lymph node assay using flow cytometry. | 2012 Mar 25 |
Sample Use Guides
Isoeugenol is effective at low concentrations of 10 to 20 mg/L corresponding to active ingredient concentrations of 5 to 10 mg/L.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12828253
Isoeugenol in low concentrations 206 uM caused a distinct decrease in twitch response in phrenic nerve-diaphragm preparations.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m6486
Created by
admin on Fri Dec 15 17:01:12 GMT 2023 , Edited by admin on Fri Dec 15 17:01:12 GMT 2023
|
PRIMARY | Merck Index | ||
|
50543
Created by
admin on Fri Dec 15 17:01:12 GMT 2023 , Edited by admin on Fri Dec 15 17:01:12 GMT 2023
|
PRIMARY | |||
|
5912-86-7
Created by
admin on Fri Dec 15 17:01:12 GMT 2023 , Edited by admin on Fri Dec 15 17:01:12 GMT 2023
|
PRIMARY | |||
|
DTXSID901025644
Created by
admin on Fri Dec 15 17:01:12 GMT 2023 , Edited by admin on Fri Dec 15 17:01:12 GMT 2023
|
PRIMARY | |||
|
2A4KEV8DNH
Created by
admin on Fri Dec 15 17:01:12 GMT 2023 , Edited by admin on Fri Dec 15 17:01:12 GMT 2023
|
PRIMARY | |||
|
227-633-7
Created by
admin on Fri Dec 15 17:01:12 GMT 2023 , Edited by admin on Fri Dec 15 17:01:12 GMT 2023
|
PRIMARY | |||
|
1549041
Created by
admin on Fri Dec 15 17:01:12 GMT 2023 , Edited by admin on Fri Dec 15 17:01:12 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD